Oral abstract| Volume 85, ISSUE 5, SUPPLEMENT , AB56-AB57, May 2017

153 Increasing Adenoma Detection Rate Over Time in a National Benchmarking Registry

      The GI Quality Improvement Consortium (GIQuIC) is a benchmarking clinical registry developed in collaboration with the ACG and ASGE. This registry prospectively collects colonoscopy data including pathology, providing the opportunity for benchmarking and quality improvement. The adenoma detection rate (ADR) is the proportion of individuals undergoing a complete screening colonoscopy who have one or more adenomas detected. Higher ADRs have been inversely correlated with interval colorectal cancer risk. The recommended benchmarks for ADR on screening colonoscopy have been 15% in women and 25% in men but has recently been increased to 20% and 30% respectively. GIQUIC includes over 4,000 physicians and 3,500,000 colonoscopies and provides an opportunity to assess overall ADRs and ADR trends in a large group of endoscopists.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gastrointestinal Endoscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect